Market Report Source

Overview

Datamonitor’s MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Healthcare industry.

Table of Contents

Pharmaceutical Company Round-up
Page – 3

Cancer Update
Page 4 – News Round-up
Page 6 – Opinion: Abraxis BioScience: Abraxane will face strong competition in Europe
Page 7 – Opinion: Bayer/Onyx Pharmaceuticals: Nexavar approved for kidney cancer in Japan

Cardiovascular Update
Page 8 – News Round-up
Page 10 – Feature Analysis – Trial fails to ENHANCE Vytorin’s prospects
Page 12 – Feature Analysis – HbA1c: how low should you go?

Central Nervous System Update
Page 13 – News Round-up
Page 15 – Opinion: UCB: set to expand its stake in the epilepsy market
Page 16 – Opinion: Eli Lilly: set to move into the neurology sector
Page 17 – Opinion: Apitope Technology: MS vaccine shows promise in Phase I/IIa
Page 18 – Opinion: EpiCept: positive NP-1 trials point to potential in neuropathic pain market

IDI Update
Page 19 – News Round-up
Page 21 – Opinion: Novo Nordisk: setback for inhaled insulin
Page 22 – Opinion: No ‘silver bullet’ cure for obesity epidemic

Infectious Diseases Update
Page 23 – News Round-up
Page 25 – Opinion: MRSA: high incidence rates linked to gay population raise concerns
Page 26 – Opinion: Tibotec/Johnson & Johnson: Intelence provides new option in late-stage HIV
Page 27 – Opinion: Genetic link to HSV offers new targets for drug development
Page 28 – Opinion: Roche: Tamiflu resistance found in Europe
Page 29 – Opinion: Sanofi Aventis: highlighting vaccines as strategic priority
Page 30 – Feature Analysis – Infectious disease market: patent expiries force leading players to adapt

Company Spotlight
Page 32 – Bayer AG

Biotechnology Update
Page 38 – Biotech News Round-up
Page 40 – Opinion: Genzyme: following the RNA therapy trend

Biotechnology Company Spotlight
Page 41 – Progenics

Further Reading
Page 46

Index
Page 47 – Pharma companies
Page 47 – Biotech companies
Page 48 – Key drugs